SCHEMBL22712836

SCHEMBL22712836

Brc1ccccc1N1c2ccccc2[Si](c2ccccc2)(c2ccccc2)c2ccccc21

nearest known ligand 0.44

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 1/20 0.44
▸ GSK3A P49840 1/20 0.30
▸ GSK3B P49841 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20022915 0.81 ALDH1A1 (0.36) MGLL
SCHEMBL20152426 0.79 CYP1A2 (0.31) —
SCHEMBL20022902 0.78 KDM5A (0.31) —
SCHEMBL19035965 0.77 — —
SCHEMBL20383361 0.76 GAA (0.35) MGLL
SCHEMBL20022898 0.75 MGLL (0.31) MGLL
SCHEMBL20152424 0.75 MGLL (0.44) MGLLGSK3AGSK3B
SCHEMBL15434896 0.75 MGLL (0.62) MGLLGSK3AGSK3B
SCHEMBL20022918 0.74 FAAH (0.40) MGLL
SCHEMBL15960558 0.74 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250160196-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND FUSED POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO. LTD. (KR) 2025-05-15 — — US disclosed
US-12256633-B2 Organic electroluminescence device and fused polycyclic compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2025-03-18 — — US disclosed
US-20200381634-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND FUSED POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2020-12-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200381634-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND FUSED POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE PIEZO1, ODC1, LEF1 MGLL 3568/4885GSK3A 2831/4885GSK3B 3091/4885
US-20250160196-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND FUSED POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE PIEZO1, ODC1, LEF1 MGLL 3568/4885GSK3A 2831/4885GSK3B 3091/4885
US-12256633-B2 Organic electroluminescence device and fused polycyclic compound for organic electroluminescence device PIEZO1, ODC1, LEF1 MGLL 3568/4885GSK3A 2831/4885GSK3B 3091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback